ENvue Medical, Inc. (FEED) stock
FEEDOTCOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
$0.50+0.13 (+34.73%)
Close on Oct 19, 2026Market cap $3.08MP/E –Yield –
ENvue Medical operating margin
Operating margin is operating income as a percentage of revenue.
ENvue Medical's operating margin for the twelve months ending Jun 30, 2026 was -1362.7%. For fiscal 2025 it was -896.6%, against -140.0% the year before. The highest annual figure on record is -140.0% in fiscal 2024.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -896.6% | −756.5 |
| FY2024 | Dec 31, 2024 | -140.0% | +10.5 |
| FY2023 | Dec 31, 2023 | -150.5% | +516.0 |
| FY2022 | Dec 31, 2022 | -666.5% | −331.2 |
| FY2021 | Dec 31, 2021 | -335.3% | +422.2 |
| FY2020 | Dec 31, 2020 | -757.5% | +214.4 |
| FY2019 | Dec 31, 2019 | -971.9% | +381.3 |
| FY2018 | Dec 31, 2018 | -1353.1% | −59.8 |
| FY2017 | Dec 31, 2017 | -1293.3% | −282.0 |
| FY2016 | Dec 31, 2016 | -1011.4% | −42.6 |
| FY2015 | Dec 31, 2015 | -968.7% | −372.2 |
| FY2014 | Dec 31, 2014 | -596.6% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -2290.4% | −1485.5 |
| Q1 FY2026 | Mar 31, 2026 | -568.3% | −387.6 |
| Q4 FY2025 | Dec 31, 2025 | -4748.1% | −4439.5 |
| Q3 FY2025 | Sep 30, 2025 | -311.2% | −53.2 |
| Q2 FY2025 | Jun 30, 2025 | -804.9% | −722.4 |
| Q1 FY2025 | Mar 31, 2025 | -180.7% | −119.0 |
| Q4 FY2024 | Dec 31, 2024 | -308.6% | −248.9 |
| Q3 FY2024 | Sep 30, 2024 | -258.0% | −111.7 |
| Q2 FY2024 | Jun 30, 2024 | -82.5% | +260.7 |
| Q1 FY2024 | Mar 31, 2024 | -61.7% | +236.4 |
| Q4 FY2023 | Dec 31, 2023 | -59.6% | +892.9 |
| Q3 FY2023 | Sep 30, 2023 | -146.3% | +115.2 |
| Q2 FY2023 | Jun 30, 2023 | -343.2% | +65.6 |
| Q1 FY2023 | Mar 31, 2023 | -298.0% | +25.8 |
| Q3 FY2022 | Sep 30, 2022 | -952.6% | −778.6 |
| Q2 FY2022 | Jun 30, 2022 | -261.4% | +50.2 |
| Q1 FY2022 | Mar 31, 2022 | -408.8% | +866.9 |
| Q4 FY2021 | Dec 31, 2021 | -323.9% | +1387.2 |
| Q3 FY2021 | Sep 30, 2021 | -173.9% | +362.1 |
| Q2 FY2021 | Jun 30, 2021 | -311.6% | +234.1 |
| Q1 FY2021 | Mar 31, 2021 | -1275.7% | −480.1 |
| Q4 FY2020 | Dec 31, 2020 | -1711.1% | −287.0 |
| Q3 FY2020 | Sep 30, 2020 | -536.0% | +249.1 |
| Q2 FY2020 | Jun 30, 2020 | -545.7% | −205.0 |
| Q1 FY2020 | Mar 31, 2020 | -795.6% | +2018.3 |
| Q4 FY2019 | Dec 31, 2019 | -1424.1% | +1099.9 |
| Q3 FY2019 | Sep 30, 2019 | -785.1% | +1670.4 |
| Q2 FY2019 | Jun 30, 2019 | -340.7% | +284.3 |
| Q1 FY2019 | Mar 31, 2019 | -2813.9% | −1788.0 |
| Q4 FY2018 | Dec 31, 2018 | -2524.1% | −1071.2 |
| Q3 FY2018 | Sep 30, 2018 | -2455.6% | −1512.5 |
| Q2 FY2018 | Jun 30, 2018 | -625.0% | +644.2 |
| Q1 FY2018 | Mar 31, 2018 | -1026.0% | +516.3 |
| Q4 FY2017 | Dec 31, 2017 | -1452.9% | −717.4 |
| Q3 FY2017 | Sep 30, 2017 | -943.1% | – |
| Q2 FY2017 | Jun 30, 2017 | -1269.2% | – |
| Q1 FY2017 | Mar 31, 2017 | -1542.3% | – |
| Q2 FY2016 | Jun 30, 2016 | -735.5% | – |
See a number that looks wrong?